Initial results from the First in Human (FIH) Phase 1 trial evaluating AIC468, a 2nd generation antisense oligonucleotide (ASO), in…
– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel long-acting herpes simplex virus helicase-primase…
Partners with The Global Centre for Healthy Workplaces & Arogya World, to host Global Healthy Workplace Summit & Awards. This…
LONDON, July 18, 2025 /PRNewswire/ -- On July 22, the World Federation of Neurology (WFN) will celebrate its 12th annual…
New deal win TCV at $1.8 billion LONDON and NOIDA, India, July 14, 2025 /PRNewswire/ -- HCLTech (NSE: HCLTECH) (BSE: HCLTECH),…
MOMENCE, Ill., June 5, 2025 /PRNewswire/ -- New research published in the International Journal of Molecular Sciences shows that vitAlign®, a proprietary and…